Identified cases of acute hepatitis C from computerized laboratory database: A hospital-based epidemiological and clinical study

Journal of Infection

Volumn 56, Issue 4, 2008, Pages 274-280

  Hung, Chao Hung ^a   Lu, Sheng Nan ^a,b   Wang, Jing Houng ^a   Hung, Shu Fen ^a   Chen, Chien Hung ^a   Hu, Tsung Hui ^a   Lee, Chuan Mo ^a   Changchien, Chi Sin ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b XIAMEN CHANG GUNG HOSPITAL   (China)

Author keywords

Acute hepatitis C; Anti HCV titer; antiviral therapy; Epidemiology; Seroconversion

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ANTIVIRUS AGENT; BILIRUBIN; HEPATITIS C ANTIBODY; PEGINTERFERON; RIBAVIRIN; VIRUS RNA;

ACUPUNCTURE; ADULT; ANAMNESIS; ANTIBODY TITER; ARTICLE; BLOOD TRANSFUSION; BODY PIERCING; CASE CONTROL STUDY; CONTROLLED STUDY; DENTAL CARE; DISEASE COURSE; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL INFORMATION SYSTEM; HUMAN; INFORMATION PROCESSING; INJECTION; INTERVIEW; INTRAVENOUS DRUG ABUSE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PLASMA CLEARANCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SEROCONVERSION; SEXUAL TRANSMISSION; SURGICAL PATIENT; TATTOOING; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ALGORITHMS; ANTIVIRAL AGENTS; CASE-CONTROL STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS B ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOENZYME TECHNIQUES; LABORATORIES, HOSPITAL; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; TAIWAN;

EID: 41349119791     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2008.01.049     Document Type: Article

References (37)

1. Alter M.J. Epidemiology of hepatitis C in the West. Semin Liver Dis 15 (1995) 5-14
2. Seeff L.B., Hollinger F.B., Alter H.J., et al. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a National Heart, Lung, and Blood Institute collaborative study. Hepatology 33 (2001) 455-463
3. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. N Engl J Med 340 (1999) 1228-1233
4. Pape G.R., Gerlach T.J., Diepolder H.M., Grüner N., Jung M., and Santantonio T. Role of the specific T-cell response for clearance and control of hepatitis C virus. J Viral Hepat 6 Suppl. 1 (1999) 36-40
5. Wiese M., Berr F., Lafrenz M., Porst H., and Oesen U. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicenter study. Hepatology 32 (2000) 91-96
6. Liang T.J., Rehermann B., Seeff L.B., and Hoofnagle J.H. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 132 (2000) 296-305
7. Vogt M., Lang T., Frösner G., et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 341 (1999) 866-870
8. Parana R., Vitvitski L., Andrade Z., et al. Acute sporadic non-A, non-B hepatitis in northeastern Brazil: etiology and natural history. Hepatology 30 (1999) 289-293
9. Micallef J.M., Kaldor J.M., and Dore G.J. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 13 (2006) 34-41
10. Orland J.R., Wright T.L., and Cooper S. Acute hepatitis C. Hepatology 33 (2001) 321-327
11. Marcellin P. Hepatitis C the clinical spectrum of the disease. J Hepatol 26 (1999) 9-16
12. Martinelli A.L., Brown D., Braun H.B., Michel G., and Dusheiko G.M. Quantitative assessment of hepatitis C virus RNA and IgM antibodies to hepatitis C core in chronic hepatitis C. J Hepatol 24 (1996) 21-26
13. Papatheodordis G.V., Delladetsima J.K., Katsoulidou A., et al. Significance of IgM anti-HCV core level in chronic hepatitis C. J Hepatol 27 (1997) 36-41
14. Lu S.N., Tung H.D., Chen T.M., et al. Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti-HCV titre rather than by seroconversion?. J Viral Hepat 11 (2004) 563-570
15. Jaeckel E., Cornberg M., Wedemeyer H., et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 345 (2001) 1452-1457
16. Nomura H., Sou S., Tanimoto H., et al. Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial. Hepatology 39 (2004) 1213-1219
17. Murphy E.L., Bryzman S.M., Glynn S.A., et al. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS). Hepatology 31 (2000) 756-762
18. Alter M.J. Hepatitis C virus infection in the United States. J Hepatol 31 Suppl. 1 (1999) 88-91
19. Vrielink H., Reesink H.W., van den Burg P.J., et al. Performance of three generations of anti-hepatitis C virus enzyme linked immunosorbent assays in donors and patients. Transfusion 37 (1997) 845-849
20. Hennig H., Schlenke P., Kirchner H., Bauer I., Schulte-Kellinghaus B., and Bludau H. Evaluation of newly developed microparticle enzyme immunoassays for the detection of HCV antibodies. J Virol Methods 84 (2000) 181-190
21. Barrera J.M., Bruguera M., Ercilla M.G., et al. Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C. Hepatology 21 (1995) 639-644
22. Garson J.A., Tuke P.W., Makris M., et al. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis C virus contaminated factor VIII concentrates. Lancet 336 (1990) 1022-1025
23. Prince A.M., Brotman B., Inchauspe G., et al. Patterns and prevalence of hepatitis C virus infection in posttransfusion non-A, non-B hepatitis. J Infect Dis 167 (1993) 1296-1301
24. Gerlach J.T., Diepolder H.M., Zachoval R., et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 125 (2003) 80-88
25. Cox A.L., Netski D.M., Mosbruger T., et al. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis 40 (2005) 951-958
26. Lu S.N., Chue P.Y., Chen H.C., et al. Different viral etiology of hepatocellular carcinoma between two hepatitis B and C endemic townships in Taiwan. J Gastroenterol Hepatol 12 (1997) 547-550
27. Lu S.N., Lee C.M., Changchien C.S., et al. Excess mortality from hepatocellular carcinoma in an HCV-endemic Township of an HBV-endemic country. Trans R Soc Trop Med Hyg 93 (1999) 600-602
28. Sun C.A., Chen H.C., Lu S.N., et al. Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors. J Med Virol 65 (2001) 30-34
29. Centers for Disease Control of Taiwan. Infectious disease statistics and surveillance annual report. 2006;11:95-97.
30. Huang W.S., Lu S.N., Wang J.H., et al. Prediction of viremia for cases of hepatitis C virus (HCV) infection using a third-generation anti-HCV enzyme immunoassay test. Hepatogastroenterology 52 (2005) 893-896
31. Tung H.D., Lu S.N., Lee C.M., et al. Antiviral treatment responses in patients with chronic hepatitis C virus infection evaluated by a third generation anti-hepatitis C virus assay. J Viral Hepat 9 (2002) 304-308
32. Giuberti T., Ferrari C., Marchelli S., et al. Long-term follow-up of anti-hepatitis C virus antibodies in patients with acute non-A non-B hepatitis and different outcome of liver disease. Liver 12 (1992) 94-99
33. Yuki N., Hayashi N., Hagiwara H., et al. Changes in antibodies to specific hepatitis C virus antigens with interferon-alpha therapy: analysis by recombinant immunoblot assay. Am J Gastroenterol 88 (1993) 914-918
34. Huang J.F., Lu S.N., Chue P.Y., et al. Hepatitis C virus infection among teenagers in an endemic township in Taiwan: epidemiological and clinical follow-up studies. Epidemiol Infect 27 (2001) 485-492
35. Lefrere J.J., Guiramand S., Lefrere F., et al. Full or partial seroreversion in patients infected by hepatitis C virus. J Infect Dis 175 (1997) 316-322
36. Spada E., Mele A., Berton A., et al. Multi-specific T-cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance. Gut 53 (2004) 1673-1681
37. Hwang S.J., Lee S.D., Lu R.H., et al. Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C. J Med Virol 65 (2001) 505-509